AUROPHARMA jumped +4.4% on a box breakout

Strota Newsroom · session of 2026-08-31 · market close · AUROPHARMA stock page →

Aurobindo Pharma Ltd. (AUROPHARMA) jumped +4.4% to ₹1,717.00 with 4 signals firing. Here is what the exchange data shows.

Aurobindo Pharma ended the session 4.36% higher at ₹1,717.00, closing at the day's high and at a fresh 52-week high. The stock opened with a 0.2% gap-up, rose from its previous close of ₹1,645.30, and traded across a ₹1,635.10–₹1,717.00 band, while the Nifty slipped just 0.04%, so the strength was stock-specific.

The tape was convincing. Volume ran 4.5x its normal level, the price held 1.81% above its VWAP, and the stock's futures traded at a 1.02% premium to spot — a bullish tick in the derivatives shelf. On the charts Aurobindo triggered a Darvas breakout and is sitting above both its 50- and 200-day averages, with the 14-day RSI at 68.9 and relative volume of 2.43.

The momentum readings are striking. Over the past week the stock is up 6.778% and over the past month 8.657%, and it is 68.98% above its 52-week low. A report from Business Standard noted the stock had spurts 3.36% and was gaining for a fifth straight session, while Univest flagged the fresh 52-week high.

The news backdrop is earnings-led. Reuters reported that Aurobindo posted a quarterly profit rise on anti-retroviral drug demand, and GuruFocus recapped a Q1 2027 earnings call highlighting record revenue growth. A separate note from Simply Wall St pointed to a modest fair-value lift as analysts reworked their assumptions. There was no negative headline in the pack to counter the move.

What the data establishes is a clean breakout to a 52-week high on strong volume and a positive earnings narrative, with the futures premium confirming the tone. What it does not establish is how much further the run extends — at a 52-week high with the RSI near 69, the stock is extended, and the data shows no fresh catalyst beyond the earnings and re-rating already in the price.

The numbers

Signals that fired

Technical context

Volume ran at 2.4× its 20-day average; rsi(14) sits at 69; price is 0.0% from the 52-week high; trading above the 50-dma and 200-dma.

Recent headlines

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.